In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantroe moderately slowing the progression of the disease and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone moderately shlowing the progression of the disease and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone moderatey slowing the progression of the disease and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disese and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitodxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence suports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone moderately slowing the progression of the dishease and decreasing rates of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing ratezs of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rats of relapses over two years
In this population tentative evidence supports mitoxantrone moderately slowing the progression of the disease and decreasing rates of relapses over two years|In this population tentative evidence supports mitoxantrone dmoderately slowing the progression of the disease and decreasing rates of relapses over two years
